Cancer Research Is a Global Mission

Cancer does not recognize borders. It touches lives everywhere — in small villages and big cities, across every continent and culture. Because of this, the search for better cancer treatments and cures must also be global.

As a cancer researcher who grew up in Taiwan, studied in the United States, and now teaches and conducts research at China Medical University in Taiwan, I have seen firsthand how different countries bring unique strengths to the fight against cancer. And I believe it’s time we shine a brighter light on the growing contributions coming from Asia, especially from Taiwan.

Too often, global cancer research is viewed through a Western lens. But in recent years, Taiwanese scientists, clinicians, and institutions have been quietly — and steadily — making major strides that deserve recognition and celebration.

Taiwan: Small Island, Big Impact

Taiwan may be small in size, but it punches well above its weight in scientific innovation. With a strong national healthcare system, high rates of education, and advanced technology infrastructure, Taiwan is uniquely positioned to conduct world-class research — particularly in the biomedical and life sciences.

When it comes to cancer, Taiwan has been investing heavily in prevention, diagnosis, and treatment. Our National Health Insurance system provides a rich source of population data for research, allowing scientists to track trends, outcomes, and new therapies across large groups of patients.

In addition, Taiwan’s government and academic institutions have created strong research partnerships — which help us stay connected to global advancements while contributing our own insights.

China Medical University: A Rising Research Powerhouse

As a professor at China Medical University (CMU), I’ve witnessed the university’s transformation into a leader in cancer research. Founded in 1958, CMU has grown rapidly, and now includes a large teaching hospital, research institutes, and collaborations with international medical centers.

CMU is particularly active in:

• Translational research that Bruges basic science to drug discovery
  
• Integrative approaches combining Western and traditional Chinese medicine
  

One of our proudest achievements is the establishment of the Translational Cancer Research Center, which brings together laboratory scientists, clinicians, and data analysts to move discoveries from the lab directly into patient care. We’re also involved in joint publications with top-tier institutions in the U.S. and Japan.

For me, this kind of integrated, cross-disciplinary environment is exactly what cancer research needs. It’s not just about the science — it’s about connection, collaboration, and care.

Innovations Coming Out of Taiwan

Here are just a few areas where Taiwan is making real contributions to global cancer research:

1. Genomic Medicine and Big Data

Taiwan is home to some of the most comprehensive national health databases in the world. These resources are helping researchers identify cancer risk factors, develop early detection methods, and personalize treatments based on genetic information. Our work in bioinformatics and AI-powered diagnosis tools is attracting international attention.

2. Early Detection Through Screening Programs

Taiwan’s national screening programs for breast, cervical, and colorectal cancer have been remarkably effective. These efforts have led to earlier diagnoses, improved survival rates, and valuable lessons for other countries building their own screening systems.

3. Herbal and Natural Product Research

Many labs, including those at CMU, are exploring how traditional Chinese medicine and herbal compounds can complement modern cancer therapies. Some compounds are being tested for their ability to reduce side effects from chemotherapy or boost immune response — an exciting area of integrative oncology.

4. Global Collaboration Networks

Taiwanese scientists are not working in isolation. Through exchange programs, dual-degree partnerships, and co-authored research, we are contributing to the international conversation around cancer care. This includes joint studies on cancer disparity and novel drug resistance mechanisms.

Women in Research: A Growing Force in Taiwan

As a female scientist, I’m also proud to see more Taiwanese women entering leadership roles in medicine and research. The culture is shifting. At CMU and other institutions, young women are taking up space in labs, giving keynote talks at international conferences, and receiving recognition for their work.

In the US, organizations like Women in Cancer Research (WICR) are helping foster that momentum, but we still have a long way to go — especially in ensuring women have equal opportunities in publishing, grant funding, and institutional leadership.

The Road Ahead: Challenges and Opportunities

Of course, we still face challenges. Like many Asian countries, Taiwan must balance innovation with funding limitations, keep up with fast-changing technologies, and ensure that research findings are quickly translated into clinical practice.

But with our strong foundation, talented researchers, and increasing global engagement, I believe the future is bright. Taiwan is no longer just contributing to global cancer research — we are helping shape its future.

Taiwan Roots, Global Reach

As a Taiwanese researcher, I carry a pride in our culture, our resilience, and our scientific contributions. But I also see myself as part of a much larger story — the global fight against cancer.

When we share our findings, work across borders, and lift each other up, we all win. Taiwan’s role in this movement is growing, and I’m honored to be part of it.

To every student, colleague, and collaborator: let’s keep pushing forward, together. Cancer doesn’t stand a chance when we stand united.